Moderna is one of the leading American biotechnology companies that aims to develop a COVID-19 vaccine. The company announced that will it soon release the status of their vaccine.

(Photo : Reutersconnect/Dado Ruvic)
Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Moderna logo in this illustration.

Pfizer has already announced that its COVID-19 vaccine is 90 percent effective against the infectious and deadly virus.

So far, they are the leading company that asked health regulators permission to sell the vaccine at the end of this month. 

Read also: COVID-19: Analysis Shows Pfizer's Vaccine is 90% Effective in Phase 3 Trial

Meanwhile, the Moderna biotechnology company has just finished gathering the data for the first analysis of its COVID-19 vaccine.

The company is expected to announce on Wednesday the efficacy of its vaccine before the end of this month. 

Pfizer and Moderna are both developing the COVID-19 vaccine using a brand new technology called mRNA.

Pfizer conducted their Stage 3 Human Clinical Trial with 44,000 subjects in the U.S. and in other countries, while Moderna is conducting its clinical trial with 33,000 subjects. 

According to a report in CNN News, half of the 33,000 received the Moderna's COVID-19 vaccine while the other half is the placebo group that received a shot of saline that does not nothing.

This is just one of the processes to make sure that the vaccine is safe and effective. 

Read also: Health Experts Raise Safety Concerns for Pfizer's COVID-19 Vaccine 

Typically, the U.S. Food and Drug Administration will release an authorization for Moderna after several tests.

Moderna hit the 53 mark on Wednesday but the company still does not know how many of them received the vaccine and the placebo. 

Moreover, Moderna is now preparing to send the data they gathered in their last stage of Human Clinical Trial to an independent panel of experts, Data and Safety Monitoring Board.
The board will look into how many of the participants who became ill received the vaccine and the placebo. 

If the board will find that a significant number received the placebo, that means the vaccine is effective.

Hence, those who received Moderna's COVID-19 vaccine were able to protect themselves against the infectious and deadly virus.

Status to be announced by the end of month

The company firmly believe that the independent panel of experts will release the efficacy of their vaccine before the end of the month. Typically, the U.S. FDA gives green light for a vaccine if it shows a promising result two months after the last stage of the Human Clinical Trial. 

Dr. Anthony Fauci, the country's leading disease and infectious expert, said that Pfizer's COVID-19 results are good news for the Moderna as well. This is primarily because both companies are using the same technology in developing the vaccine. 

Fauci told the Financial Times that the two vaccines hold promising results.

"Moderna has an almost identical mRNA. We hope we're going to see a similar kind of result from Moderna. If we do, then we'll have two vaccines in play."

In fact, Fauci said that the results of Pfizer's mRNA vaccine were better than what is expected.

Fauci asserted, "I really quite honestly did not expect that we would have a result as striking as this -- more than 90%, close to 95% efficacy -- on the first vaccine that went through the gate."